Autoimmune Disease Testing and Triggers

Autoimmune Disorders: A Growing Concern – We Can Help

  • Approximately 50 million Americans, 20 Percent of the population or one in five people, suffer from autoimmune diseases.
  • Symptoms cross many specialties and can affect all body organs.
  • Medical education provides minimal learning about autoimmune disease.
  • Specialists are generally unaware of interrelationships among the different autoimmune diseases or advances in treatment outside their own specialty area.
  • Initial symptoms are often intermittent and unspecific until the disease becomes acute.
  • Research is generally disease-specific and limited in scope. More information-sharing and crossover among research projects on different autoimmune diseases is needed.

Cyrex is focused on the fast growing health issues of autoimmune disorders now affecting tens of millions of people in the United States. Cyrex test panels are designed to evaluate your immune reactions using a proprietary, advanced technology.

As a CLIA licensed clinical laboratory, our innovative tests provide advanced clinical tools to identify and measure immune reactivity and possible autoimmune reactivity that can affect multiple tissues such as:

Cognitive Health

Identify and address the early signs of Alzheimer’s disease.

Recommended if you:

  • Are interested in preventing the development of Alzheimer’s disease or other neurological disorder.
  • Are exhibiting early signs of Alzheimer’s disease or other neurological disorder.
  • Have been diagnosed with Alzheimer’s disease.
  • Have a history of gastrointestinal disorders and/or diabetes.
  • Played high-impact sports.
  • Are immunoreactive against specific pathogens, chemicals and foods.

Alzheimer’s LINX – Alzheimer’s-Associated Immune Reactivity

Essential Barriers

Evaluation of the intestinal and blood-brain barrier integrity. When there is a a breach in essential defense barriers, the body is at risk for developing environmentally-induced autoimmunity.

Recommended if you:

  • Are interested in preventing the development of Alzheimer’s disease or other neurological disorder. Array 2, 20 or 22
  • Are exhibiting early signs of Alzheimer’s disease or other neurological disorder. Array 20
  • Have been diagnosed with Alzheimer’s disease. Array 2, 20 or 22.
  • Have a history of gastrointestinal disorders and/or diabetes. Array 2 or 22
  • Played high-impact sports- Array 20.
  • Are immuno-reactive against specific pathogens, chemicals and foods.

Array 2 – Intestinal Antigenic Permeability Screen­™
Array 20 – Blood-Brain Barrier™
Array 22 – Irritable Bowel/SIBO Screen™

Predictive Antibodies

Identify autoimmune reactivity at its early stages. Measures predictive autoantibodies, some of which can appear up to 10 years before any clinical symptoms. Efficiently and economically assesses possible tissue damage to multiple organs of the body.

Recommended if you:

  • Have a diagnosed autoimmune disorder, as there is a 25% chance of developing another condition
  • Have chronic increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders

Array 5 – Multiple Autoimmune Reactivity Screen™
Array 6 – Diabetes Autoimmune Reactivity Screen™
Array 7 – Neurological Autoimmune Reactivity Screen™
Array 7X – Neurological Autoimmune Reactivity Screen™ – Expanded
Array 8 – Joint Reactivity Screen™

Environmental Triggers

Identifies immune reactivity to environmental triggers which include dietary proteins, chemicals and heavy metals.

Recommended if you:

  • Have non-responsive GI symptoms.
  • Present multiple symptom complaints (including Chronic Fatigue Syndrome and Fibromyalgia).
  • Suffer from depression or neuro-autoimmunity.

Array 3X – Wheat/Gluten Proteome Reactivity & Autoimmunity™
Array 4 – Gluten-Associated Cross-Reactive Foods & Foods Sensitivity™
Array 10 – Multiple Food Immune Reactivity Screen™
Array 10-90 – Multiple Immune Reactivity Screen™
Array 10-90X – Multiple Food Immune Reactivity Screen™
Array 11 – Chemical Immune Reactivity Screen™
Array 12 – Pathogen-Associated Immune Reactivity Screen™

Mucosal Immune

The first array to encompass the Cyrex System measuring both SIgA and SIgM
GAM assesses overall production of Immunoglobulin G, Immunoglobulin A and Immunoglobulin M in the body—an important measurement of general immunity. Total immunoglobulins testing can be a strong indicator of a disease or condition.

Recommended to verify:

  • Current status of your immune system
  • Antibody production

Array 14 – Mucosal Immune Reactivity Screen™

The Immune Load Reduction™ System
What is Your Immune System Load™?

You wouldn’t know unless you Get Tested.

We help you identify key challenges to your immune system so you can reduce the immune load.